Leukemia-Derived Dendritic Cells can be Generated from Blood or Bone Marrow Cells from Patients with Acute Myeloid Leukaemia: A Methodological Approach under Serum-Free Culture Conditions-Reference-Cited by-同舟云学术

Leukemia-Derived Dendritic Cells can be Generated from Blood or Bone Marrow Cells from Patients with Acute Myeloid Leukaemia: A Methodological Approach under Serum-Free Culture Conditions

Published:2005-07 Issue:1 Volume:62 Page:86-98
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:Scand J Immunol

Author:

Kufner S.,Zitzelsberger H.,Kroell T.,Pelka-Fleischer R.,Salem A.,de Valle F.,Schweiger C.,Nuessler V.,Schmid C.,Kolb H. J.,Schmetzer H. M.

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3083.2005.01630.x/fullpdf

Reference49 articles.

1. Acute Myeloid Leukemia

2. Immunophenotyping of leukemia

3. 6-Thioguanine, Cytarabine, and Daunorubicin (TAD) and High-Dose Cytarabine and Mitoxantrone (HAM) for Induction, TAD for Consolidation, and Either Prolonged Maintenance by Reduced Monthly TAD or TAD-HAM-TAD and One Course of Intensive Consolidation by Sequential HAM in Adult Patients at All Ages With De Novo Acute Myeloid Leukemia (AML): A Randomized Trial of the German AML Cooperative Group

4. Dendritic cells in vaccination therapies of malignant diseases

5. Origin, maturation and antigen presenting function of dendritic cells

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparative Study of B Cell Blast Isolation Methods from Bone Marrow Aspirates of Pediatric Leukemia Patients;Biopreservation and Biobanking;2024-04-30

2. Volatile Phases Derived from Serum, DC, or MLC Culture Supernatants to Deduce a VOC-Based Diagnostic Profiling Strategy for Leukemic Diseases;Biomolecules;2023-06-14

3. Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes;International Journal of Molecular Sciences;2022-12-27

4. Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DCleu);Clinical Immunology;2020-08

5. Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia;Transfusion Medicine and Hemotherapy;2020